STEVENSON, Md., Feb. 27, 2017 -- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Eastern District of New York on behalf of purchasers of Cemtrex, Inc. (Nasdaq:CETX) (“Cemtrex” or the “Company”) securities during the period between December 7, 2016 and February 21, 2017, inclusive (the “Class Period”). Investors who wish to become proactively involved in the litigation have until April 25, 2017 to seek appointment as lead plaintiff.
If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement for the class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in Cemtrex securities during the Class Period. Members of the class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff. No class has yet been certified in the above action.
The complaint accuses the defendants of violations of the Securities Exchange Act of 1934 by virtue of the defendants’ failure to disclose during the Class Period that over $1 million had been paid to stock promoters since late 2015; the entity paying for the stock promotion was owned by the Company’s Chief Executive Officer (“CEO”) and President and based out of Cemtrex’s corporate headquarters; senior executives engaged in undisclosed insider selling; and, the Company retained a foreign accounting firm with a history of fraudulent endeavors to conduct its financial audits.
According to the complaint, following a February 22, 2017 article asserting that money had been paid to stock promoters by the Company’s CEO, the value of Cemtrex shares declined significantly.
If you have suffered a loss in excess of $100,000 from investment in Cemtrex securities purchased on or after December 7, 2016 and held through the revelation of negative information during and/or at the end of the Class Period and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, without cost or obligation to you, please visit our website at http://www.browerpiven.com/currentsecuritiescases.html. You may also request more information by contacting Brower Piven either by email at [email protected] or by telephone at (410) 415-6616. Brower Piven also encourages anyone with information regarding the Company’s conduct during the period in question to contact the firm, including whistleblowers, former employees, shareholders and others.
Attorneys at Brower Piven have extensive experience in litigating securities and other class action cases and have been advocating for the rights of shareholders since the 1980s. If you choose to retain counsel, you may retain Brower Piven without financial obligation or cost to you, or you may retain other counsel of your choice. You need take no action at this time to be a member of the class.
CONTACT: Charles J. Piven Brower Piven, A Professional Corporation 1925 Old Valley Road Stevenson, Maryland 21153 Telephone: 410-415-6616 [email protected]


Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
China’s LandSpace Takes Aim at SpaceX With Reusable Rocket Ambitions
Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
Trump Administration Probes Corporate DEI Programs, Raising Questions for Google Stock
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring
Winter Storm Disrupts Northeast Travel as Snow and Ice Blanket New York, New Jersey 



